BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Award details

Commercialisation of a new platform technology for peptide synthesis

ReferenceBB/P022839/1
Principal Investigator / Supervisor Dr Steven Burston
Co-Investigators /
Co-Supervisors
Institution University of Bristol
DepartmentBiochemistry
Funding typeResearch
Value (£) 12,069
StatusCompleted
TypeResearch Grant
Start date 04/01/2017
End date 03/04/2017
Duration3 months

Abstract

unavailable

Summary

unavailable
Committee Not funded via Committee
Research TopicsIndustrial Biotechnology
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund Pathfinder (FOF-Path) [2014-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file